These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2149513)

  • 1. Left ventricular hypertrophy reversal with labetalol and propranolol: a prospective randomized, double-blind study.
    Szlachcic J; Hall WD; Tubau JF; Porter V; Vollmer C; Wollam G; Hirsch A; Massie B
    Cardiovasc Drugs Ther; 1990 Apr; 4(2):427-33. PubMed ID: 2149513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of labetalol on left ventricular mass and function in hypertension--an assessment by serial echocardiography.
    Kaul U; Mohan JC; Bhatia ML
    Int J Cardiol; 1984 Apr; 5(4):461-73. PubMed ID: 6233228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regression of left ventricular hypertrophy in treated hypertensive patients with dilevalol and metoprolol--a double blind randomized study.
    Glasser SP; Koehn DK; Powell R
    J Clin Pharmacol; 1989 Sep; 29(9):791-7. PubMed ID: 2572609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of propranolol and diltiazem on systolic and diastolic left ventricular function in essential hypertension.
    Ramanathan KB; Ratts TE; Griffin B; Sullivan JM
    J Hum Hypertens; 1990 Dec; 4(6):677-86. PubMed ID: 2096210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left ventricular changes after chronic therapy with enalapril maleate in moderate to severe hypertensive patients.
    Fernandez PG; Kim BK; Snedden W; Nolan R; Ko P
    Curr Med Res Opin; 1984; 9(3):170-83. PubMed ID: 6094104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The correlation of changes in systolic blood pressure with regional anatomical regression of hypertensive left ventricular hypertrophy in patients on chronic antihypertensive therapy (greater than 1 year): alpha-methyldopa compared to propranolol.
    Fernandez PG; Kim BK; Reichek N; Ko P; Gill V; McDonald J; Furlong L; Lewis H; Nolan R; McManamon P
    Curr Med Res Opin; 1984; 8(10):720-33. PubMed ID: 6233093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of single-dose atenolol, labetalol, and propranolol on cardiac and vascular function.
    Holtzman JL; Finley D; Johnson B; Berry DA; Sirgo MA
    Clin Pharmacol Ther; 1986 Sep; 40(3):268-73. PubMed ID: 3742933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel therapeutic approach for reversal of left ventricular hypertrophy and blood pressure control in hypertensive patients treated with alpha-methyldopa or propranolol.
    Fernandez PG; Snedden W; Kim BK; Lee CC
    Can J Physiol Pharmacol; 1985 Apr; 63(4):304-8. PubMed ID: 3159468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Labetalol compared with propranolol in the treatment of black hypertensive patients.
    Saunders E; Curry C; Hinds J; Kong BW; Medakovic M; Poland M; Roper K
    J Clin Hypertens; 1987 Sep; 3(3):294-302. PubMed ID: 3312502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regression of left ventricular hypertrophy in "previously untreated" hypertensive blacks after 6 months of blood pressure reduction with alpha- and beta-adrenergic blockade and thiazide therapy.
    Foster E; Plehn JF; Bernard SA; Battinelli NJ; Huntington-Coats M; Apstein CS
    Cardiovasc Drugs Ther; 1992 Apr; 6(2):147-51. PubMed ID: 1390327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue velocity echocardiography shows early improvement in diastolic function with irbesartan and atenolol therapy in patients with hypertensive left ventricular hypertrophy. Results form the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA).
    Müller-Brunotte R; Kahan T; Malmqvist K; Ring M; Edner M
    Am J Hypertens; 2006 Sep; 19(9):927-36. PubMed ID: 16942935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of labetalol and propranolol on the peripheral circulation in hypertensive patients.
    Nyberg G; Berglund G
    Acta Med Scand Suppl; 1982; 665():93-101. PubMed ID: 6961763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dilevalol compared with propranolol and placebo for systemic hypertension.
    Schoenberger JA; Frishman WH; Wallin JD; Gorwit J; Davidov ME; Michelson EL; Bedsole GD; Cubbon J; Poland MP
    Am J Cardiol; 1989 Jun; 63(19):45I-49I. PubMed ID: 2658529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time course of regression of left ventricular hypertrophy in treated hypertensive patients.
    Wollam GL; Hall WD; Porter VD; Douglas MB; Unger DJ; Blumenstein BA; Cotsonis GA; Knudtson ML; Felner JM; Schlant RC
    Am J Med; 1983 Sep; 75(3A):100-10. PubMed ID: 6226186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A controlled trial of labetalol (Trandate), propranolol and placebo in the management of mild to moderate hypertension.
    Pugsley DJ; Nassim M; Armstrong BK; Beilin L
    Br J Clin Pharmacol; 1979 Jan; 7(1):63-8. PubMed ID: 367410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Labetalol compared with propranolol in patients with both angina pectoris and systemic hypertension: a double-blind study.
    Frishman WH; Shapiro W; Charlap S
    J Clin Pharmacol; 1989 Jun; 29(6):504-11. PubMed ID: 2666451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression of left ventricular hypertrophy and systolic function in hypertensive patients during long-term treatment with ketanserin.
    Coto V; Cocozza M; Oliviero U; Lucariello A; Picano T; Castaldo B; Iovino V; Cacciatore L
    Cardiovasc Drugs Ther; 1990 Jan; 4 Suppl 1():77-80. PubMed ID: 2149516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combined alpha- and beta-adrenergic blocker labetalol and propranolol in the treatment of high blood pressure: similarities and differences.
    Weber MA; Drayer JI; Kaufman CA
    J Clin Pharmacol; 1984; 24(2-3):103-12. PubMed ID: 6143765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter double-blind study of the efficacy and safety of once and twice daily dilevalol compared to propranolol.
    Schoenberger JA; Wallin JD; Gorwit JI; Davidov ME; Michelson EL; Poland MP; Frishman WH
    Am J Hypertens; 1989 Nov; 2(11 Pt 1):840-6. PubMed ID: 2686711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postmarketing comparison of labetalol and propranolol in hypertensive patients.
    Due DL; Giguere GC; Plachetka JR
    Clin Ther; 1986; 8(6):624-31. PubMed ID: 3791361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.